These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1206 related articles for article (PubMed ID: 30153805)

  • 1. Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection.
    Brown JR; Flemer B; Joyce SA; Zulquernain A; Sheehan D; Shanahan F; O'Toole PW
    BMC Gastroenterol; 2018 Aug; 18(1):131. PubMed ID: 30153805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent Clostridium difficile infection.
    Seekatz AM; Theriot CM; Rao K; Chang YM; Freeman AE; Kao JY; Young VB
    Anaerobe; 2018 Oct; 53():64-73. PubMed ID: 29654837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent
    Mullish BH; McDonald JAK; Pechlivanis A; Allegretti JR; Kao D; Barker GF; Kapila D; Petrof EO; Joyce SA; Gahan CGM; Glegola-Madejska I; Williams HRT; Holmes E; Clarke TB; Thursz MR; Marchesi JR
    Gut; 2019 Oct; 68(10):1791-1800. PubMed ID: 30816855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal Bile Acid Composition Changes Following Faecal Microbiota Transplantation for Clostridioides difficile Infection in Children With and Without Underlying Inflammatory Bowel Disease.
    Chen LA; Oliva-Hemker M; Radin A; Weidner M; O'Laughlin BD; Sears CL; Javitt NB; Hourigan SK
    J Crohns Colitis; 2023 Aug; 17(8):1364-1368. PubMed ID: 36988432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
    Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
    PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in the bile acid-farnesoid X receptor-fibroblast growth factor pathway.
    Monaghan T; Mullish BH; Patterson J; Wong GK; Marchesi JR; Xu H; Jilani T; Kao D
    Gut Microbes; 2019; 10(2):142-148. PubMed ID: 30183484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Faecal microbiota transplantation for
    Terveer EM; Vendrik KE; Ooijevaar RE; Lingen EV; Boeije-Koppenol E; Nood EV; Goorhuis A; Bauer MP; van Beurden YH; Dijkgraaf MG; Mulder CJ; Vandenbroucke-Grauls CM; Seegers JF; van Prehn J; Verspaget HW; Kuijper EJ; Keller JJ
    United European Gastroenterol J; 2020 Dec; 8(10):1236-1247. PubMed ID: 32990503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection.
    Weingarden AR; Chen C; Bobr A; Yao D; Lu Y; Nelson VM; Sadowsky MJ; Khoruts A
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G310-9. PubMed ID: 24284963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation.
    Staley C; Kelly CR; Brandt LJ; Khoruts A; Sadowsky MJ
    mBio; 2016 Dec; 7(6):. PubMed ID: 27999162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the mechanisms of efficacy of fecal microbiota transplant in treating recurrent
    Martinez-Gili L; McDonald JAK; Liu Z; Kao D; Allegretti JR; Monaghan TM; Barker GF; Miguéns Blanco J; Williams HRT; Holmes E; Thursz MR; Marchesi JR; Mullish BH
    Gut Microbes; 2020 Nov; 12(1):1810531. PubMed ID: 32893721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised clinical trial: faecal microbiota transplantation for recurrent Clostridum difficile infection - fresh, or frozen, or lyophilised microbiota from a small pool of healthy donors delivered by colonoscopy.
    Jiang ZD; Ajami NJ; Petrosino JF; Jun G; Hanis CL; Shah M; Hochman L; Ankoma-Sey V; DuPont AW; Wong MC; Alexander A; Ke S; DuPont HL
    Aliment Pharmacol Ther; 2017 Apr; 45(7):899-908. PubMed ID: 28220514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial taxonomic and metabolic alterations during faecal microbiota transplantation to treat Clostridium difficile infection.
    Kellingray L; Gall GL; Defernez M; Beales ILP; Franslem-Elumogo N; Narbad A
    J Infect; 2018 Aug; 77(2):107-118. PubMed ID: 29746938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal Microbiota Transplantation Increases Colonic IL-25 and Dampens Tissue Inflammation in Patients with Recurrent Clostridioides difficile.
    Jan N; Hays RA; Oakland DN; Kumar P; Ramakrishnan G; Behm BW; Petri WA; Marie C
    mSphere; 2021 Oct; 6(5):e0066921. PubMed ID: 34704776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
    Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
    Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiome and plasma lipidome analysis reveals a specific impact of
    Arcay R; Barceló-Nicolau M; Suárez L; Martín L; Reigada R; Höring M; Liebisch G; Garrido C; Cabot G; Vílchez H; Cortés-Lara S; González de Herrero E; López-Causapé C; Oliver A; Barceló-Coblijn G; Mena A
    mBio; 2024 Oct; 15(10):e0134724. PubMed ID: 39189787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential biomarkers to predict outcome of faecal microbiota transfer for recurrent Clostridioides difficile infection.
    Farowski F; Solbach P; Tsakmaklis A; Brodesser S; Cruz Aguilar MR; Cornely OA; Dettmer K; Higgins PG; Suerbaum S; Jazmati N; Oefner PJ; Vehreschild MJGT;
    Dig Liver Dis; 2019 Jul; 51(7):944-951. PubMed ID: 30770201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation.
    Staley C; Kaiser T; Vaughn BP; Graiziger CT; Hamilton MJ; Rehman TU; Song K; Khoruts A; Sadowsky MJ
    Microbiome; 2018 Sep; 6(1):166. PubMed ID: 30227892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiome changes associated with sustained eradication of Clostridium difficile after single faecal microbiota transplantation in children with and without inflammatory bowel disease.
    Hourigan SK; Chen LA; Grigoryan Z; Laroche G; Weidner M; Sears CL; Oliva-Hemker M
    Aliment Pharmacol Ther; 2015 Sep; 42(6):741-52. PubMed ID: 26198180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease.
    Khanna S; Vazquez-Baeza Y; González A; Weiss S; Schmidt B; Muñiz-Pedrogo DA; Rainey JF; Kammer P; Nelson H; Sadowsky M; Khoruts A; Farrugia SL; Knight R; Pardi DS; Kashyap PC
    Microbiome; 2017 May; 5(1):55. PubMed ID: 28506317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects on luminal and mucosal microbiota and commonly acquired taxa in faecal microbiota transplantation for recurrent Clostridium difficile infection.
    Jalanka J; Mattila E; Jouhten H; Hartman J; de Vos WM; Arkkila P; Satokari R
    BMC Med; 2016 Oct; 14(1):155. PubMed ID: 27724956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.